Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Gene expression profiles of the established erythroid progenitor cell lines estimated by quantitative RT-PCR analysis. Analyzed genes are indicated. FL, results with cDNA derived from human fetal liver. Relative expression was evaluated compared to that of FL. CB, cord blood. CB 6, 10 and 16, results with cDNA derived from cultured erythroid cells, i.e., CD34-positive cells in CB were induced to differentiate into mature erythroid cells for 6, 10 and 16 days, respectively, using the previously reported method [4]. B and A, Before and 2 days after induction of differentiation of HiDEP and HUDEP cells.](https://figures.cochat.ai/paper-figures/2c1a4cd9be89480c8e81cf1b067b0b83/establishment-of-immortalized-human-erythroid-progenitor-cell-lines-able-to-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, overexpression of CBL and CNN1 transgenes in a human erythroid progenitor model (HUDEP2 cells) individually and in combination also induced markers of erythroid differentiation (Fig. 3F–G and fig. S10C–D) (21).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · cited 1×
“Of note, BCL11A, a repressor of c-globin expression [25] and critical mediator of globin switching [26], was abundantly detected only in the HUDEP-2 cell line in which b-globin was up-regulated after differentiation (Figure 7).”
BackgroundMikkola, H. K. A., Klintman, J., Yang, H., Hock, H., Schlaeger, T. M., Fujiwara, Y., & Orkin, S. H. (2003) · Nature · doi:10.1038/nature01345 · Cited by 371 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
KARASAWA, S., ARAKI, T., NAGAI, T., MIZUNO, H., & MIYAWAKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20040321 · Cited by 342 · cited 1×
“The CSIV-TRE-RfA-UbC-KT lentiviral vector plasmid (Figure S2) contains the humanized Kusabira-Orange 1 (hKO1) fluorescent protein gene [11] and the reverse tetracycline (Tet)-controlled transcriptional transactivator (TAKARA BIO) linked by the Thosea asigna virus 2A peptide sequence under the control of human ubiquiti…”
BackgroundBiologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
Background
Cited by
Items 301–400 of 418
Erythropoiesis and Megakaryopoiesis in a Dish
Varga, E., Hansen, M., van den Akker, E., & Lindern, M. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80638 · Cited by 4
“The HiDEP, HUDEP, and BEL-A express embryonic, fetal, and adult Hbs, respectively [101, 107].”
BackgroundTauroursodeoxycholic acid improves viability of artificial RBCs
Hong, S. H., Yoon, K. J., Lim, K., Um, Y. J., Cho, J. G., Jo, Y. J., & Park, S. G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.003 · Cited by 3
Immortalisation érythrocytaire pour production de globules rouges in vitro
Caulier, A., Guyonneau-Harmand, L., & Garçon, L. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.06.030 · Cited by 3
“Rare” reagent red cells: rare no longer?
Chou, S. T. (2018) · Transfusion · doi:10.1111/trf.14958 · Cited by 3
“Specifically, they use HiDEP-1 (human iPSC-derived erythroid progenitor) cells that are immortalized but can undergo maturation when cultured in medium that specifically supports erythroid differentiation.(2) They demonstrate that these in vitro–derived red cells express some red cell antigens (D, C, e, k, Di) at suff…”
MethodATF4 mediates fetal globin upregulation in response to reduced β-globinPreprint
Boontanrart, M. Y., Stehli, G., Banović, M., Schröder, M., Wyman, S. K., Lew, R., Bordi, M., Gowen, B. G., DeWitt, M. A., & Corn, J. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.15.905943 · Cited by 3
“To mechanistically investigate how β0-stress caused by knockout of HBB upregulates HBG, we used the HUDEP-2 cord-blood derived erythroid progenitor cell line (Kurita et al., 2013).”
MethodChu, S. N., Soupène, E., Wienert, B., Yin, H., Sharma, D., McCreary, T., Jia, K., Homma, S., Hampton, J. P., Gardner, J. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.01.555926 · Cited by 3
“To determine cleavage frequencies, we delivered candidate gRNAs pre-complexed with Cas9 protein to the human HUDEP-2 cell line via electroporation 17 .”
MethodFelder, A.-K., Tjalsma, S. J. D., Verhagen, H. J. M. P., Majied, R., Verstegen, M. J. A. M., Verheul, T. C. J., Mohnani, R., Gremmen, R., Krijger, P. H. L., Philipsen, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.13.632719 · Cited by 3
Liu, J., Park, K., Shen, Z., Ye, Y., Lee, E., Herman, R. A., Zhu, X., Lu, W., Nuhfer, J., Bassal, M. A., et al. (2024) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2024.150861 · Cited by 5
A one-base therapeutic insertion in the HBG2 distal promoter reactivates γ-globin expression
Bao, X., Gao, Y., Chen, X., Wang, Z., Feng, X., Wang, L., Du, J., Ye, Y., Chen, F., Du, L., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00626-7 · Cited by 2
“HUDEP-2 cells were cultured and differentiated as previous described [22, 23].”
PPIL2 is a target of the JAK2/STAT5 pathway and promotes myeloproliferation via degradation of p53
Wang, P., Han, X., Ren, K., Li, E., Bi, H., Aydemir, I., SUKHANOVA, M. J., Liu, Y., Yang, J., & Ji, P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci181394 · Cited by 4
Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression
Perfetto, M., Danoff, A., Ishfaq, M., Monroe, H., Mohideen, A., Chen, M., Tejero, J., Stratman, A. N., Okawa, S., & Yien, Y. Y. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014887 · Cited by 3
Segura, E., Hart, K. L., Fernandez, B. C., Brown, D., Tam, K., Garcia, A. G., Seigneurbieux, E., Li, K., Mulumba, C., Blakely, E., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102362 · Cited by 2
“17 These HUDEP-2 cells were further gene edited into an α -globin knockout (KO) cell line with a homozygous 20 kb deletion encompassing both HBA2/1 genes (a-KO HUDEP-2).”
Zhu, J., Chin, K., Zou, J., Aerbajinai, W., Lin, W.-C., Li, H., & Rodgers, G. P. (2025) · Blood · doi:10.1182/blood.2025029969 · Cited by 2
Goswami, S. G., Gupta, P., Arvinden, V. R., Bhargava, N., Iyer, A. R., Saravanakumar, V., Yadav, P., Jha, S. K., Singh, S., Kumar, A., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04582-1 · Cited by 2
“HUDEP-2 cells, an immortalized erythroid progenitor cell line generously provided by Profs. Yukio Nakamura and Ryo Kurita from the RIKEN BioResource Research Center, Japan, were cultured following previously established protocols [37].”
Self-citationFinotti, A., Gasparello, J., Zuccato, C., Cosenza, L. C., Fabbri, E., Bianchi, N., & Gambari, R. (2023) · Genes · doi:10.3390/genes14101927 · Cited by 3
“It will be of interest will be in future studies to employ experimental systems and cell lines derived from patients, such as the HUDEP-1 and HUDEP-2 cell lines, that have been recently used in experimental projects similar to our study [69,70].”
ResultNishigaya, Y., Takase, S., Sumiya, T., Sato, T., Niwa, H., Sato, S., Nakata, A., Matsuoka, S., Maemoto, Y., Hashimoto, N., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129856 · Cited by 3
Kurita, R., ABE, T. K., Maebara, K., Takahashi, D., Miyata, S., Satake, M., & Tani, Y. (2025) · Allergology International · doi:10.1016/j.alit.2025.03.003 · Cited by 2
Self-citationRBC substitutes: from the past to the future
Choe, W., & Baek, E. J. (2015) · ISBT Science Series · doi:10.1111/voxs.12153 · Cited by 2
Génération de globules rouges de culture à partir de cellules souches : bref récit du futur
Mazurier, C., & Douay, L. (2016) · Biologie Aujourd hui · doi:10.1051/jbio/2016008 · Cited by 2
Generating Blood from iPS Cells
Karagiannis, P., Endô, H., & Eto, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_19 · Cited by 2
Kovilakath, A., Mohamad, S., Hermes, F., Wang, S. Z., Ginder, G. D., & Lloyd, J. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_16 · Cited by 3
“These originate from umbilical cord blood hematopoietic stem/progenitor cells and induced pluripotent stem cells, respectively [7].”
BackgroundWeiner, L., & Brissette, J. L. (2022) · FEBS Journal · doi:10.1111/febs.16542 · Cited by 2
ZNF410 represses fetal globin by devoted control of CHD4/NuRDPreprint
Vinjamur, D. S., Yao, Q., Cole, M. A., McGuckin, C., Ren, C., Zeng, J., Hossain, M., Luk, K., Wolfe, S. A., Pinello, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.272856 · Cited by 2
The epigenetic eraser LSD1 lies at the apex of a reversible erythroid to myeloid cell fate decisionPreprint
Yu, L., Myers, G., Ku, C.-J., Schneider, E., Wang, Y., Singh, S. A., Jearawiriyapaisarn, N., White, A. D., Moriguchi, T., Khoriaty, R. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.13.426552 · Cited by 2
Impact assessment of exploratory wells offshore south Florida
Shinn, E. A., Lidz, B. H., & Dustan, P. (1989) · doi:10.67297/000bae · Cited by 4
Brusson, M., Chalumeau, A., Martinucci, P., Romano, O., Poletti, V., Scaramuzza, S., Ramadier, S., Masson, C., Ferrari, G., Mavilio, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.31.522279 · Cited by 2
Xu, S., Peng, C., Ren, R., Lu, H., Zhao, H., Xia, S., Shen, Y., Xu, B., Zhang, H., Cheng, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115476 · Cited by 1
TRIM10β upregulation promotes microtubule destabilization and triggers proteotoxic stress
Kim, H., Shin, W., Jeon, B., Lee, S., & Park, B. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112052 · Cited by 1
Murine hematopoietic progenitor cell lines with erythroid and megakaryocyte potential
Wu, R., Moghadam, F. S., Redecke, V., Ma, Z., Marchetti, M., Finkelstein, D., Xu, P., Cheng, Y., Queisser, K. A., Petrey, A. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62668-z · Cited by 3
Fujiwara, T., & Harigae, H. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2553648 · Cited by 1
“47,61 In this model, we observed changes in the expression levels of genes related to iron metabolism and a potential link to ferroptosis, an iron-dependent form of cell death induced by the accumulation of lipid peroxides.”
Gao, Z.-Y., Yang, Z.-X., Deng, D.-H., Zhang, F., Yu, B., Zhang, Y., Lv, X., Nakamura, Y., Gong, A., Cheng, T., et al. (2025) · Blood Science · doi:10.1097/bs9.0000000000000253 · Cited by 2
“HUDEP2 erythroid progenitors, kindly provided by Dr R. Kurita, 28 were expanded in StemSpan SFEM II (Stemcell Technologies, Vancouver, British Columbia, Canada) containing 50 ng/mL human stem-cell factor, 3 U/mL erythropoietin (EPO), 1 µM dexamethasone, and 10 µg/mL doxycycline.”
Self-citationThe histone methyltransferase MLL1 complex inhibits expression of fetal hemoglobin
Han, Y., Gudmundsdottir, B., Gudmundsson, K. O., Roy, K. R., Tisdale, J. F., & Du, Y. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110863 · Cited by 1
“To test this possibility, we transduced human erythroblast HUDEP-2 cells (39) with independent lentiviral shRNAs targeting KMT2A and a nontargeting control shRNA and examined the effects of KMT2A downregulation on the expression of γ - and ε -globin.”
Stage-specific TRIM10 expression regulates erythroid maturation
Kim, H., Shin, W., Lee, D., Jeon, B., Kim, Y., Shin, D., Jeong, H., Hong, J. Y., Lee, S., & Park, B. (2025) · EMBO Reports · doi:10.1038/s44319-025-00616-0 · Cited by 1
“To explore how TRIM10a expression dynamics in fl uence erythroid maturation, we utilized HUDEP-2 cells, widely used for studying terminal erythroid differentiation (Daniels et al, 2020; Doer fl er et al, 2021; Feng et al, 2022; Kurita et al, 2013).”
MAZ regulates fetal hemoglobin repression by activating MYB transcription
Lu, D., Yang, Y., Yang, B., Chen, D., Zhu, M., Huang, S., Hu, J., Zhu, L., Fan, W., Xie, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30733-8 · Cited by 1
“To investigate the role of MAZ in HBG regulation, we employed shRNAs to knockdown MAZ in a human adult-type erythroid cell line HUDEP-2 31 .”
InfluentialThe GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis
Ling, T., Bezavada, L., Mehmood, R., Zhang, K., Cotton, A., Crawford, J. C., Jin, H. E., Sona, S., Li, L., Ju, Y., et al. (2026) · Blood · doi:10.1182/blood.2025030464 · Cited by 1
Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model
Karsenty, C. L., Betancourth, D., Cao, M., Pham, Q.-K., Park, S. H., & Bao, G. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102854 · Cited by 1
“We engineered a dual-fluorescent sickle HUDEP2 cell model (SHD GFP/BFP ) from the parental sickle HUDEP2 (SHD) line, 18–20 which carries a homozygous sickle mutation, by introducing a P2A-GFP-pA cassette at the HBB C-terminus via HDR, generating a biallelic SHD GFP/GFP clone.”
Zin, T. N., Jatavan, P., Sakunpansa, N., Charoenkwan, P., & Khamphikham, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-54128-5 · Cited by 1
“Chery-Bart’s cells were established using a tetracycline-inducible system to drive HPV16 E6 and E7 expression, an established method for immortalizing erythroid progenitor cells used in other models 23,30,31 .”
InfluentialDissecting polycomb complexes for enhanced fetal hemoglobin production
Kaminski, P. J., Min, K., Traxler, E. A., Khandros, E., Abdulmalik, O. Y., Godfrey, B. N., Keller, C. A., Giardine, B. M., Hardison, R. C., Shi, J., et al. (2026) · Blood · doi:10.1182/blood.2026033804 · Cited by 1
Xu, C., Cui, H., Fang, Q., Wang, H., Tu, P., & Cui, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121971 · Cited by 1
Blood Generation from Stem Cells: An Overview
(2016) · International Journal of Science and Research (IJSR) · doi:10.21275/v5i3.nov162280 · Cited by 1
New Concepts in Transfusion Medicine
Maitta, R. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54458-0.00015-5 · Cited by 1
Innovation of Transfusion Medicine with iPS Cells
Sugimoto, N., & Eto, K. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.843 · Cited by 1
Zhou, G., & Lu, D. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104957 · Cited by 1
Wang, X., McKillop, W. M., Dlugi, T. A., Faber, M. L., Argote, J. A., Chambers, C. B., Wilber, A. C., & Medin, J. A. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3567 · Cited by 3
Hu, X., Wang, J., Yang, K., Fan, H., Wu, J., Ren, J., Han, G., Li, J. Y., Xue, Z., Liu, X., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302017r · Cited by 3
Nishigaya, Y., Takase, S., Sumiya, T., Kikuzato, K., Hiroyama, T., Maemoto, Y., Aoki, K., Sato, T., Niwa, H., Sato, S., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117721 · Cited by 2
Self-citationMiyazawa, M., Kawai, K., Yamamoto, S., & Kitagawa, D. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103934 · Cited by 1
“10 Additionally, we present the staining of suspended HeLa cells, an adherent cell line, indicating its potential application for analyzing adherent cell suspensions, for example, during cell sorting experiments or when cell adhesion is affected.”
Cell sources for large‐scale manufacture of red blood cells
Kim, S., & Baek, E. J. (2018) · ISBT Science Series · doi:10.1111/voxs.12430 · Cited by 1
Xu, L., Wei, W., Qian, J., Zhang, S., Jin, Z., Wang, X., Li, L., Gu, Y., Lv, Y., Zhao, C. N., et al. (2022) · medRxiv · doi:10.1101/2022.08.18.22278875 · Cited by 3
“To test whether downregulation of MS4A3 is required to promote the maturation of RBCs in humans, we applied HUDEP-2, a human cord HSC-derived erythroid progenitor cell line that can be induced to differentiate into mature RBCs (Kurita et al., 2013).”
MethodHuman erythroid progenitors express antigen presentation machineryPreprint
Clements, R. L., Kennedy, E. A., Song, D. H., Campbell, A. D., An, H. H., Amses, K. R., Miller-Ensminger, T., Addison, M. M., Eisenlohr, L. C., Chou, S. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.27.601047 · Cited by 1
“To better understand kinetics of MHC II expression, we utilized immortalized Human Umbilical cord blood-Derived Erythroid Progenitor (HUDEP-2) cells 53 .”
MethodA Novel XACT lncRNA Transcript with Functions Transcending X-Chromosome InactivationPreprint
Zhang, P., Angles, P. H., Zhang, H., Li, T., Mulet‐Lazaro, R., van IJcken, W. F. J., Philipsen, S., Delwel, R., Gribnau, J. H., Huylebroeck, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.03.631201 · Cited by 1
Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cellsPreprint
Yu, M., Das, P., Horton, J. R., Zhou, J., Lee, J. J., Hong, T., Lu, Y., Estecio, M. R., Iakova, P. A., Jain, A. K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.06.704516 · Cited by 1
Browne, S. M., & Al‐Rubeai, M. (2013) · Cell engineering · doi:10.1007/978-94-007-7196-3_5
Mao, B., Lu, X., Huang, S.-K., Yu, J., Lai, M., Tsuji, K., Nakahata, T., & Ma, F. (2015) · SpringerBriefs in stem cells · doi:10.1007/978-94-017-7312-6_2
“Many efforts have been made for this purpose, such as optimizing the formula of differentiation medium [51], using semipermeable membranes to save complementary molecules in medium [5], replacing cytokines with cheaper mimetics [52], adding specific small molecules to increase expansion folds of erythroid precursors […”
BackgroundBullock, T., Bruce, L. J., & Ridgwell, K. (2016) · Transfusion Medicine · doi:10.1111/tme.12316
Direct lineage reprogramming: a useful addition to the blood cell research toolbox
Capellera-Garcia, S., & Flygare, J. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2017.1272409 · Cited by 2
Elucidation of Mechanisms of Fetal Hemoglobin Regulation by CRISPR/Cas9 Mediated Genome Editing
Canver, M. C. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
BAP1 deubiquitinase is a potent repressor of fetal hemoglobin biosynthesisPreprint
Yu, L., Jearawiriyapaisarn, N., Lee, M. P., Hosoya, T., Wu, Q., Myers, G., Lim, K.-C., Kurita, R., Nakamura, Y., Vojtek, A. B., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/346619
“To ask whether any new proteins could be identified as novel components of the DRED complex that were not co-purified in our original affinity proteomics study, BirA* was fused to the N-terminus of TR4 and then TR4-BirA* was stably transfected into HUDEP-2 cells, which upon cytokine stimulation produces mature definit…”
BackgroundInfluentialSelf-citationEngineering Red Blood Cell Progenitors to Achieve Greater Proliferative Potential
Mayers, S. J. (2015) · TSpace (University of Toronto)
Modelling Ineffective Erythropoiesis in Myelodysplastic Syndromes with Ring Sideroblasts
Elvarsdóttir, E. M. (2019) · Figshare · doi:10.13140/rg.2.2.13726.28485
Flipping the Hemoglobin Switch and Discovering Regulators Involved in Fetal Hemoglobin Reactivation
Boontanrart, M. Y. (2020) · eScholarship (California Digital Library)
O switching de globinas na diferenciação hematopoética in vitro
Ferreira, A. R. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-19012021-120625
Ferguson, D. C. J., MacInnes, K. A., Daniels, D. E., & Frayne, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822230-0.00006-5 · Cited by 2
Blood Pharming – eine realistische Option?
Kronstein‐Wiedemann, R., Thiel, J., & Tonn, T. (2021) · Transfusionsmedizin · doi:10.1055/a-1342-0820
“Zelltyp Ursprung Immortalisierungs-Faktor Feederzellen HämoglobinExpression Expansionsfaktor Enukleationsrate klinische Entwicklung Literatur native HSC/PCs KM oder PBabgeleitete CD34+-Zellen none MSCs oder MS-5 Zell-Linie β-Globin 1 × 105 > 95% Phase I [15, 44] CB-abgeleitete CD34+Zellen none ohne Feederzellen γ- und…”
BackgroundInfluentialDevelopmental maturation of the hematopoietic system controlled by a Lin28b- let - 7 -PRC1 axisPreprint
Wang, D., Tanaka-Yano, M., Meader, E., Kinney, M. A., Morris, V., da Rocha, E. L., Liu, N., Orkin, S. H., North, T. E., Daley, G. Q., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.05.474696
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732374185.793577763
Han, Y., Wang, S., Wang, Y., Huang, Y., Gao, C., Guo, X., Chen, L., Zhao, H., & An, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.15.545026
George, A., Ravi, N. S., Vaishnavi, B., Marepally, S. K., Thangavel, S., Velayudhan, S. R., Srivastava, A., & Mohankumar, K. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.04.569931
Xu, S., Ren, R., Peng, C., Lu, H., Ly, L. C., Crossley, M., Xu, B., Cheng, X., Blobel, G. A., & Lan, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.24.581901
Métral, S., Genetet, S., Gamain, B., & Mouro-Chanteloup, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-76897-7
Revisiting γ-globin gene repression by TR4
Perkins, A. C. (2024) · Blood · doi:10.1182/blood.2024026481
MLL1 complex is a critical regulator of fetal hemoglobin repressionPreprint
Han, Y., Gudmundsdottir, B., Gudmundsson, K. O., Roy, K. R., Tisdale, J. F., & Du, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.24.645036
Roberts, K., Zhang, S., Khulan, B., Yan, Z., Muia, J., Mulvey, J. J., Olivier, E. N., Pullman, J. M., Cataland, S. R., & Bouhassira, E. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.659386
Kim, M. J., Kim, H. J., Kim, S., & Kim, H. O. (2025) · The Korean Journal of Blood Transfusion · doi:10.17945/kjbt.2025.36.2.53 · Cited by 1
Brosseau, N., Pincez, T., Lo, K. S., Beaudoin, M., & Lettre, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.20.677403
“HUDEP-2 cells were cultured as previously described 26,28 : For expansion, cells were cultured in StemSpan TM SFEM (Cedarlane #09650) supplemented with 1 µg/ml doxycycline (Sigma #D9891), 0.4 µg/ml dexamethasone (Sigma #D2915), 0.1 µg/ml Stem Cell Factor (Cedarlane #255-SC-050), 3 units/ml…”
InfluentialSite-specific Integration of Therapeutic-length Genes using TIVID SystemPreprint
Zhang, X., Gao, Z.-Y., Shen, T.-L., Cheng, C.-Y., Zhang, Y.-M., Zhang, L.-M., Zhao, X.-D., & Zhang, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7154020/v1
Myers, J. A., Couch, T., Murphy, Z. C., Malik, J. T., Getman, M. R., & Steiner, L. A. (2020) · Figshare · doi:10.6084/m9.figshare.11992482
Myers, J. A., Couch, T., Murphy, Z. C., Malik, J. T., Getman, M. R., & Steiner, L. A. (2020) · Figshare · doi:10.6084/m9.figshare.11992479
Myers, J. A., Couch, T., Murphy, Z. C., Malik, J. T., Getman, M. R., & Steiner, L. A. (2020) · Figshare · doi:10.6084/m9.figshare.11992464
Jeffery, N. N., Davidson, C., Peslak, S. A., Kingsley, P. D., Nakamura, Y., Palis, J., & Bulger, M. (2021) · Figshare · doi:10.6084/m9.figshare.15086125
Self-citationMyers, J. A., Couch, T., Murphy, Z. C., Malik, J. T., Getman, M. R., & Steiner, L. A. (2020) · Figshare · doi:10.6084/m9.figshare.11992470
Liu, M., Shen, Z., Jeong, Y. K., Yu, N. L., Wu, S., Wittig, A., Tenen, D. E., Liu, Y., Liu, J., & Chai, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.21.700828
Near completely reversing the γ- to β-globin switch by enhancer release, retargeting and reinforcingPreprint
Wang, N., Yang, K., Xie, X., Cui, S., Pei, X., Zhao, X., Hao, D., Jia, Y., Yang, G., Liu, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702713
Shen, Y., Gupta, K., Tan‐Wong, S. M., Wen, S., Fisher, C. A., Tamon, L., Proudfoot, N. J., Gibbons, R. J., & Higgs, D. R. (2026) · Nature Communications · doi:10.1038/s41467-026-69169-7
“Wildtype HUDEP-2 cells were obtained from the Cell Engineering Division, RIKEN BioResource Center, Tsukuba, Japan 64 .”
Orai1 acts as a novel Ca2+ signal switch, balancing erythropoiesis through KLF1 regulation
Lee, Y. Y., Koh, H., Kim, J., Kim, S., Lee, J., & Park, C. Y. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01651-0
LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II
Yu, L., Wang, Y., King, R., Myers, G., Deng, K., McGee, B. M., Friedman, A. D., Balbin-Cuesta, G., Lin, Z., Drysdale, C. M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adt4859 · Cited by 1
Metabolic fueling of hematopoietic stem cell differentiation to the erythroid lineage
Oburoglu, L. (2014) · theses.fr (ABES) · doi:10.70675/2a8ca582z1bd3z4b90z96c1z5964d1e426b9
Pastori, V., Łabędź, A., Simanovich, M. A., Fabiano, M. P., Frigo, C., Verheul, T. C. J., Proietti, L., Grebien, F., Citterio, E., Philipsen, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-46308-0
“They were grown in RPMI+5%FBS. HUDEP1 and HUDEP2 are human immortalized erythroid progenitor cells 12 .”
InfluentialNew therapeutic strategies for the treatment of β-hemoglobinopathies
Weber, L. (2018) · theses.fr (ABES) · doi:10.70675/09314463zdfd1z46b4z9c0cz32c6c2c5ccc2
Rôle du complexe VDAC1/TSPO1 au cours de l'érythropoïèse humaine, focus sur la mitophagie
Moras, M. (2020) · theses.fr (ABES) · doi:10.70675/a4c63cc2z949az4474zb1acz38e7f433fd35
Étude des interactions des gamétocytes de plasmodium falciparum avec les îlots érythroblastiques
Neveu, G. (2019) · theses.fr (ABES) · doi:10.70675/980995a6zdc58z4baeza611za7bbb7e3fd15
Base editing approaches for the treatment of ß-hemoglobinopathies
Hardouin, G. (2022) · theses.fr (ABES) · doi:10.70675/593cd291z9d0ez45a6z82cdz64ffb2e65ff8
Genome and epigenome editing approaches to treat β-hemoglobinopathies
Fontana, L. (2024) · theses.fr (ABES) · doi:10.70675/f1623d8bz5529z4d2dzb255z45ed273f643c
DCN1 inhibitor induces fetal hemoglobin through self-limited regulation of CUL3 neddylationPreprint
Miller, S. A., Monti, A., Zhou, E. H., Lin, C. H. S., Lynch, O., Mukherjee, S., Hei, C., Nicewonger, R., Diner, C., Macias-Garcia, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.22.720177
Reversible regulation of γ-globin expression by LRF through a BCL11A-independent mechanism
Miyazaki, M., Setoguchi, K., Masuda, T., Morikawa, T., Mehta, S., Matsumoto, S., Kunisaki, Y., Orkin, S. H., Semba, Y., & Maeda, T. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100087
Kronstein‐Wiedemann, R., Brändle, D. C., Künzel, S. R., & Tonn, T. (2026) · Transfusion Medicine and Hemotherapy · doi:10.1159/000552465
“The first proof of concept for this technology was achieved in 2013 when stable erythroid progenitor lines were generated by expressing the HPV16 E6/E7 onco-genes alongside the hematopoietic transcription factor TAL-1, which is essential for early hematopoiesis [34].”
Pate, B., Goldstein, A., Labott, M., Lizarralde-Iragorri, M. A., Chankhunthod, A. B., Tyson, T., Sloan, M., Wijeyesekera, C., Wilks, A. F., Steinberg, M. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.726003 · Cited by 2
“Alternatively, HbF induction studies widely use immortalized erythroid progenitor lines like HUDEP-2 19,20 and BEL-A 21,22 .”
Predictive modeling of signal-responsive cis -elements in human red blood cell precursors
Dogiparthi, V. R., Chee, L., Roy, P., Zhou, Y., Rowley, M. J., & Hewitt, K. J. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag505
“Human umbilical cord blood-derived erythroid progenitor 2 (HUDEP-2) cells were obtained from Yukio Nakamura’s lab [ 29 ].”
Zhang, X.-B., Gao, Z.-Y., Shen, T.-L., Cheng, C.-Y., Zhang, L., Zhang, J.-P., Zhao, X.-D., & Zhang, J.-P. (2026) · Human Gene Therapy · doi:10.1177/10430342261453040
“The HUDEP2 cell line, derived from Ryo Kurita ’ s laboratory, 45 was cultured in Serum-Free Expansion Medium II (SFEM II, StemCell Technologies) supplemented with 50 ng/mL human stem cell factor (SCF, PeproTech, Cat.”
Metadata
- Authors
- Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y.
- Affiliations
- RIKEN BioResource Research Center (JP)
- Kyushu University (JP)
- Corresponding author
- Nakamura, Yukio
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-22
- Volume
- 8
- Issue
- 3
- Pages
- e59890
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3606290
- OpenAlex
- W1974742081
- Cited by
- 418
- References
- 28
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 34 · 2023: 36 · 2022: 35 · 2021: 48 · 2020: 45 · 2019: 31 · 2018: 32 · 2017: 24 · 2016: 25 · 2015: 10 · 2014: 8 · 2013: 8
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- erythroid progenitor cells, immortalized cell lines, in vitro erythropoiesis, blood transfusion, erythroid differentiation
- MeSH terms
- Cell Nucleus, Erythrocytes, Erythropoiesis, Humans, Erythroid Precursor Cells, Erythrocyte Transfusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.